Hepatic Cell News Volume 7.17 | May 19 2023

    0
    18







    2023-05-19 | HCN 7.17


    Hepatic Cell News by STEMCELL Technologies
    Vol. 7.17 – 19 May, 2023
    TOP STORY

    Reversal of HMGA1-Mediated Immunosuppression Synergizes with Immunogenic Magnetothermodynamic for Improved Hepatocellular Carcinoma Therapy

    A ferrimagnetic vortex-domain iron oxide nanoring-based nanovehicle was developed that was able to deliver high-mobility group protein A1 (HMGA1) small interfering RNA to the cytoplasm of hepatocellular carcinoma Hepa 1–6 cells for HMGA1 pathway interference.
    [ACS Nano]

    AbstractGraphical Abstract
    Watch the Webinar On-Demand: “Re-Creating Disease with Kidney Organoids and CRISPR-Cas9”
    PUBLICATIONSRanked by the impact factor of the journal

    Intratumoral Erythroblastic Islands Restrain Anti-Tumor Immunity in Hepatoblastoma

    By single-cell RNA sequencing of 13 treatment-naive hepatoblastoma patients, scientists discovered an immune landscape characterized by aberrant accumulation of erythroblastic islands, formed by VCAM1+ macrophages and erythroid cells.
    [Cell Reports Medicine]

    Full ArticleGraphical Abstract

    COVID-19-Related Hyperglycemia is Associated with Infection of Hepatocytes and Stimulation of Gluconeogenesis

    Researchers found that COVID-19 was independently associated with in-hospital hyperglycemia and that SARS-CoV-2 was capable of infecting hepatocytes and stimulating these cells to produce glucose through gluconeogenesis.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Full Article

    The Cancer-Testis lncRNA LINC01977 Promotes HCC Progression by Interacting with RBM39 To Prevent Notch2 Ubiquitination

    Investigators discovered a novel CT-lncRNA, LINC01977, based on the Genotype-Tissue Expression and The Cancer Genome Atlas databases. LINC01977 was exclusively expressed in testes and highly expressed in HCC.
    [Cell Death Discovery]

    Full Article

    Dual Role of ANGPTL8 in Promoting Tumor Cell Proliferation and Immune Escape During Hepatocarcinogenesis

    Scientists assessed the role of angiopoietin-like protein (ANGPTL) 8, a protein secreted by HCC cells, in hepatocarcinogenesis and the mechanisms through which ANGPTL8 mediated crosstalk between HCC cells and tumor-associated macrophages.
    [Oncogenesis]

    Full Article

    E2F Target Score is Associated With Cell Proliferation and Survival of Patients sith Hepatocellular Carcinoma

    In both early (I and II) and late (III and IV) stages of HCC, a high E2F score was associated with worse survival and was an independent prognostic factor for overall and disease-specific survival in patients with HCC.
    [Surgery]

    Abstract

    Intraoperative Blood Auto-Transfusion Restrained the Malignancy of Liver Cancer via Regulating Functions of Tumor Cells and Kuffer Cells

    The role of intraoperative blood auto-transfusion in regulating the recovery of liver cancer was investigated using a rat model of liver cancer and an intraoperative blood return model. Kupffer cells were isolated from liver cancer tissues, and their biological characteristics were analyzed by flow cytometry.
    [Biotechnology and Genetic Engineering Reviews]

    Abstract

    Development of a Method of Passaging and Freezing Human iPS Cell-Derived Hepatocytes to Improve Their Functions

    To overcome issues of low proliferative capacity and difficulty in passaging due to loss of hepatic functions after reseeding hepatocyte-like cells (HLCs), scientists developed technology to dissociate, cryopreserve, and reseed HLCs in this study.
    [PLOS One]

    Full Article

    Orientin Regulates the Proliferation and Migration of Hepatocellular Carcinoma Cells

    Researchers investigated the effects of orientin on the viability, proliferation, and migration of HCC cells in vitro. They found that orientin could inhibit the proliferation, migration, and the activation of NF-κB signaling pathway in HCC cells.
    [Naunyn-Schmiedebergs Archives Of Pharmacology]

    Abstract
    Generate functional liver organoids with HepatiCult™ media
    REVIEWS

    Current Challenges and Future Perspectives in Treating Patients with NAFLD-Related Cirrhosis

    The authors critically discuss the particularities in the management of patients with non-alcoholic fatty liver disease (NAFLD)-related cirrhosis.
    [Hepatology]

    AbstractGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Elevar Therapeutics Submits New Drug Application to FDA for Combination of Rivoceranib and Camrelizumab as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma

    Elevar Therapeutics, Inc announced it submitted a New Drug Application to the US FDA for its investigational drug rivoceranib, an oral TKI, in combination with camrelizumab, a PD-1 inhibitor, as a first-line treatment option for unresectable HCC.
    [Elevar Therapeutics, Inc.]

    Press Release
    FEATURED EVENT

    The 2023 ASCO Annual Meeting

    June 2 – 6, 2023
    Chicago, Illinois, United States

    > See All Events

    JOB OPPORTUNITIES

    Research Coordinator – Liver Cancer

    Baylor College of Medicine – Houston, Texas, United States

    Postdoctoral Fellow – Tumor Microenvironment

    Centre for Oncology and Immunology – Hong Kong, Hong Kong

    PhD Student – Early Detection of Liver Cancer

    Helmholtz Association of German Research Centres – Heidelberg, Germany

    Professorships – Cell Physiology and Metabolism

    University of Geneva – Geneva, Switzerland

    Director – Liver Transplant

    University of Utah – Salt Lake City, Utah, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter